Unbiased headlines. Facts, not spin.
Unbiased Headlines is an independently owned news organization. We bring you the facts, not opinions, written fresh from 110+ named sources. Sources linked so you can verify it yourself.
DOJ Charges 15 in $1.8 Billion Southern California Health Fraud Case; FDA Case Targets Canadian Drug Importer

Two federal health care cases are moving at once. One is a Los Angeles-area fraud sweep the Justice Department puts at $1.8 billion. The other is an FDA criminal case against the top two officers of a Canadian prescription-drug company. Everything below is an allegation. No one has been convicted.
The Southern California sweep
The Justice Department charged 15 people, including six medical professionals, over fraudulent claims submitted to government and private insurers. Eight were arrested in predawn raids, and five were expected in federal court in downtown Los Angeles. FBI Director Kash Patel put total losses at $1.8 billion. Some accounts round it to $2 billion.
The biggest piece involves four defendants accused of billing private insurers more than $1.6 billion for sham substance abuse treatment. DOJ calls it the largest sober home fraud ever prosecuted. The defendants are Nathan "Pablo" Young, 39, and David "Sancho Lopez" Young, 71, of Los Angeles, and Honey Phipps, 42, and Cody Phipps, 36, of Greenville, Texas.
According to the indictment, the Youngs controlled dozens of purported treatment companies. They allegedly used "body brokers" to recruit homeless and addicted people with free flights, cash, apartments, gift cards and drugs. The Justice Department says "premium" patients with high-reimbursing insurance got hotels and dinners. "Non-premium" patients allegedly lived in housing it described as "trap houses."
Prosecutors also allege that patients who tried to leave were drugged "to knock the client out." The four face charges including conspiracy to commit health care fraud and wire fraud, and violations of the Eliminating Kickbacks in Recovery Act. Daily Wire said it contacted lawyers for the Youngs, and no lawyers were immediately listed for the Phippses.
Surgeries and hospice
Dr. Harold Tabaie, 78, an Anaheim cardiothoracic surgeon, and Hany Malek, 61, a Tarzana chiropractor, are charged in an alleged $135 million Medicare scheme. Prosecutors say Malek posed as a medical doctor, diagnosed patients with arterial disease they did not have, and recommended atherectomies. Those are invasive procedures that use a bladed catheter to clear plaque.
Tabaie allegedly performed them, sometimes repeatedly on patients whose earlier procedures had failed. Authorities say several patients suffered extreme pain. Prosecutors said billing data flagged Tabaie as an extreme national outlier.
Malek also faces charges over Paycheck Protection Program loan applications in 2021. Prosecutors allege he invented a 25% revenue loss and spent the money on personal expenses, family credit cards, other ventures and rare coins.
Three more defendants are charged in hospice schemes that allegedly enrolled seniors who were not terminally ill. The U.S. Attorney's Office also announced a nearly $270 million scheme to defraud Medi-Cal, California's Medicaid program.
"Our message is simple: if you steal health care dollars from the American taxpayer or abuse your position to harm patients, we are coming for you — and the data will lead us to you," said Assistant Attorney General Colin McDonald, who heads the department's National Fraud Enforcement Division. Patel tied the case to the White House Task Force to Eliminate Fraud, chaired by Vice President JD Vance. DOJ created the division in April. A nationwide takedown in June charged 455 defendants over $6.5 billion in alleged schemes.
Warning signs came years earlier
The Young case was not a surprise to everyone. Beverly Hills sued Nathan Young and his Rodeo Recovery in 2020. Insurer Aetna filed a $40 million civil suit in 2023 alleging his sober homes were "little more than drug dens" that encouraged relapse to restart billing cycles. Criminal charges arrived years after both filings.
The lag raises a fair question for the new fraud division: how many cases are caught by data analytics early, and how many surface only after private plaintiffs and local governments go first?
The CANARX case
In a separate FDA case, John Thomas Howard, treasurer and a director of CANARX, was arrested Sunday, Nov. 8, on smuggling and conspiracy charges. According to court records filed Tuesday, Nov. 10, he is also charged with introducing misbranded drugs into interstate commerce and illegal drug importation. No plea has been filed.
His brother Bob Howard, CANARX's president and a director, is wanted in the same investigation and was not in custody as of the filing. The charges rest on an affidavit from FDA Office of Criminal Investigations special agent Dustin Dobbs. It states there is "probable cause to believe that (CANARX) illegally imported or caused the illegal importation of prescription drugs into the United States."
The complaint covers Feb. 22, 2017, through April 15, 2026. The affidavit does not say which medications were involved.
CANARX, based in Windsor, Ontario, and founded in 2002, says it sources medications from Canada, the United Kingdom, Australia and New Zealand. It calls itself the safest program of its kind. General counsel Joseph Morris said in a statement: "The Howards deny all the charges against them, will defend vigorously, and expect to be vindicated in court."
The FDA's interest is not new. It sent CANARX a warning letter in 2019 saying the company operated in a manner that substitutes FDA-approved drugs prescribed by U.S. providers. In 2023 the agency seized CANARX-shipped medication it said was potentially misbranded and counterfeit, according to an email sent to a patient and obtained by CNBC.
CNBC's investigation last year found that companies like CANARX, known as alternative funding programs, have spread through U.S. employer health plans by offering high-cost specialty drugs at lower prices. Some employers require staff to use them. Federal authorities have said the overseas sourcing and direct-to-patient shipping is illegal and unsafe. The drugmakers have not authorized the supply chain CNBC traced.
What comes next
Five of the Los Angeles defendants were expected to appear in federal court in downtown Los Angeles. Bob Howard remains wanted, and John Thomas Howard has yet to enter a plea. The affidavit leaves open which drugs are at issue, a detail relevant to employers and patients who used these programs.
Sources used for this briefing
6 links from 5 independent newsrooms (syndicated copies of the same report count once)
These are the sources it draws on, linked so you can verify.